Study of urinary n-acetyl-beta-d-glucosaminidase as a biomarker of diabetic nephropathy

Bibliographic Information
Authors: Mahmoud A.A.; Mostafa N.M.; Mesbah O.; Sabry O.M.; Al-Barshomy S.M.
Journal: Egyptian Journal of Hospital Medicine
Publisher: Ain Shams University Faculty of Medicine
Publication Date: 1 January 2021
Volume / Issue: Volume 82 / Issue 2
Pages: 231–236
Article No.: 9
ISSN: 16872002
DOI: 10.21608/EJHM.2021.142879
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access
Authors and Affiliations
Mahmoud A.A., Departments of Internal Medicine & Nephrology, Faculty of Medicine, Zagazig University, Egypt; Mostafa N.M., Nephrology, Faculty of Medicine, Zagazig University, Egypt; Mesbah O., Nephrology, Faculty of Medicine, Zagazig University, Egypt; Sabry O.M., Hematology, Theodor Bilharz Research Institute, Egypt; Al-Barshomy S.M., Departments of Internal Medicine & Nephrology, Faculty of Medicine, Zagazig University, Egypt
Abstract
Background: Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetic patients worldwide. Plenty of tubular damage biomarkers have been discovered. Urinary N-acetyl-β-D-glucosaminidase (NAG) is a hydrolytic enzyme that acts on glycosyl compounds. NAG is excreted in abnormally high amounts in many renal diseases. Objective: The aim of this work was to study the importance of Urinary N acetyl-β-D-glucosaminidase level as an early biomarker for detection of DN and to assess the degree of kidney affection in various stages of DN. Patients and methods: 100 subjects divided into five groups: Group 1: 20 healthy volunteers (control group), group 2: 20 pre diabetic persons, group 3: 20 normo-albuminuria diabetic patients, group 4: 20 micro-albuminuria diabetic patients (ACR 3-300 mg/mmol) and group 5: 20 macro-albuminuria diabetic patients (ACR ≥ 300 mg/mmol). All individuals were subjected to full history taking, ECG & echocardiography, abdominal ultrasound, laboratory investigations (HbA1c, fasting and post prandial blood glucose, lipid profile, oral glucose tolerance test (OGTT), blood urea, serum creatinine, serum uric acid, e-GFR and urinary NAG. Results: There was high significant difference between the five groups regarding duration of the disease, fasting blood sugar, postprandial blood glucose, HbA1c, Serum cholesterol, albumin/creatinine ratio, serum urea and creatinine, e-GFR and urinary NAG. In addition, there was significant positive correlation between urinary NAG and albumin/creatinine ratio, blood urea, creatinine, and e-GFR. Conclusion: The urinary NAG can be used as an early urinary biomarker for early detection and progression of diabetic nephropathy in type 2 diabetic patients. © 2021, Ain Shams University Faculty of Medicine. All rights reserved.
Keywords
Diabetes; Nephropathy; Urinary N-Acetyl-Beta-D-glucosaminidase
Citation Information
Scopus Citations: 3
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
